Pages that link to "Q26998249"
Jump to navigation
Jump to search
The following pages link to Management of endocrine disease: Secondary osteoporosis: pathophysiology and management (Q26998249):
Displaying 25 items.
- Transforming Growth Factor β1 (TGF-β1) in the Sera of Postmenopausal Osteoporotic Females. (Q37586793) (← links)
- Risk of vertebral compression fractures in multiple myeloma patients: A finite-element study (Q37606354) (← links)
- Osteoporosis Management in Ankylosing Spondylitis. (Q38670399) (← links)
- Osteoporosis across chronic liver disease. (Q38723451) (← links)
- Risk factors for poor bone health in primary mitochondrial disease. (Q39268878) (← links)
- Descriptive study of mandibular canal visibility: morphometric and densitometric analysis for digital panoramic radiographs (Q40373283) (← links)
- Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow? (Q41273764) (← links)
- Regulation of Bone Metabolism by microRNAs (Q47730978) (← links)
- Surgery alters parameters of vitamin D status and other laboratory results (Q48237267) (← links)
- Impact of bone disease and pain in thalassemia (Q49989147) (← links)
- Bone quality changes associated with aging and disease: a review (Q51751793) (← links)
- Systematic analysis of lncRNAs, mRNAs, circRNAs and miRNAs in patients with postmenopausal osteoporosis. (Q54952463) (← links)
- Crohn's disease patient serum changes protein expression in a human mesenchymal stem cell model in a linear relationship to patients' disease stage and to bone mineral density (Q56968504) (← links)
- Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality (Q58806174) (← links)
- Risk of osteoporosis and fracture in victims with burn injury (Q64116743) (← links)
- The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma (Q64249243) (← links)
- EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research (Q64280771) (← links)
- Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment (Q88840176) (← links)
- Beyond the metabolic syndrome: Visceral and marrow adipose tissues impair bone quantity and quality in Cushing's disease (Q90716924) (← links)
- Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis (Q90731492) (← links)
- Overexpression of WNT16 Does Not Prevent Cortical Bone Loss Due to Glucocorticoid Treatment in Mice (Q91680207) (← links)
- Systemic mastocytosis: a rare cause of osteoporosis (Q91866407) (← links)
- Prevalence and risk factors for osteoporotic fracture among adults with comorbidities in Al-Ahsaa, Saudi Arabia (Q92135029) (← links)
- Chronic hyponatremia in patients with proximal femoral fractures after low energy trauma: A retrospective study in a level-1 trauma center (Q92464667) (← links)
- Hypogonadism and bone health in men with HIV (Q101136006) (← links)